Acutaas Chemicals Limited — Investor Meet, 01-02-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Financial Performance: Ami Organics Limited reported robust financial performance for Q3 FY25, with revenue from operations reaching INR 275 crore, marking a significant increase of 65.2% year-on-year and 11.5% sequentially. The gross profit surged by 78% to INR 127.2 crore, while the EBITDA stood at INR 68.7 crore, more than double from the previous year, resulting in an EBITDA margin of 25%. Profit After Tax (PAT) also experienced remarkable growth, reaching INR 45.4 crore, over 2.5 times compared to Q3 FY24. For the first nine months, revenue measured INR 698 crore, nearly matching the full previous financial year.

Future Outlook and Growth Drivers: Management is optimistic about the future, revising FY25 growth guidance from 30% to 35%, driven by anticipated growth in the CDMO business, which targets approximately INR 1,000 crore by FY28. The pharmaceutical intermediates segment witnessed an 85.7% YoY growth, while battery chemical investments are expected to bear fruit despite near-term delays.

Order Book and Operational Updates: The company expressed confidence in managing an extensive pipeline for CDMO projects, which are expected to begin commercialization by FY26. CAPEX for FY25 is in progress, focusing on multiple facilities, with successful project completions anticipated soon.

Analyst Q&A Insights: Analysts queried the sustainability of profit margins, particularly as CDMO contributions increase. Management indicated a conservative approach, projecting blended EBITDA margins might exceed 25%. Additionally, concerns about capacity utilization and future growth in specialty chemicals were addressed, emphasizing the importance of diversification across business segments.

Market or Regulatory Updates: There were discussions around the stability of pricing in the European market, which has enabled Ami Organics to set firm revenue targets and maintain margins despite external pressures.

Strategic Focus Areas: Management underscored their commitment to innovation, operational efficiency, and market expansion while navigating geopolitical uncertainties. Their focus remains on building resilience against industry fluctuations.

Investor Insight: Considering the strong financial results, significant growth potential in CDMO, and strategic focus on expanding capacity and diversifying product lines, Ami Organics exhibits promising indicators for a ‘buy’ position among retail investors, albeit with a cautious approach necessary regarding market dynamics and operational execution.